Advertisement
Canada markets close in 3 hours 17 minutes
  • S&P/TSX

    23,045.42
    +42.33 (+0.18%)
     
  • S&P 500

    5,476.98
    -18.54 (-0.34%)
     
  • DOW

    40,432.72
    -304.24 (-0.75%)
     
  • CAD/USD

    0.7360
    +0.0012 (+0.16%)
     
  • CRUDE OIL

    67.44
    +1.69 (+2.57%)
     
  • Bitcoin CAD

    77,444.69
    +156.95 (+0.20%)
     
  • XRP CAD

    0.73
    -0.00 (-0.57%)
     
  • GOLD FUTURES

    2,544.00
    +0.90 (+0.04%)
     
  • RUSSELL 2000

    2,081.86
    -15.58 (-0.74%)
     
  • 10-Yr Bond

    3.6610
    +0.0150 (+0.41%)
     
  • NASDAQ

    17,088.02
    +62.14 (+0.36%)
     
  • VOLATILITY

    19.17
    +0.09 (+0.47%)
     
  • FTSE

    8,193.94
    -12.04 (-0.15%)
     
  • NIKKEI 225

    35,619.77
    -539.39 (-1.49%)
     
  • CAD/EUR

    0.6681
    +0.0016 (+0.24%)
     

Novo Nordisk Stock Slumps As Wegovy Sales Disappoint

Novo Nordisk Stock Slumps As Wegovy Sales Disappoint

Sales of Novo Nordisk’s weight-loss injection Wegovy were lower than Wall Street analysts had expected in the second quarter, sending shares of the drugmaker down sharply on Wednesday. Novo said Wegovy sales were 11.7 billion Danish krone ($1.7 billion); the FactSet consensus estimate was 13.5 billion DKK ($2 billion).